Clinical trial: 17 volunteers given Sputnik V vaccine in Pune

By: |
December 6, 2020 5:40 PM

Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF).

As per reports, India has purchased 100 million doses of the candidate from Russia.

A total of 17 volunteers have been administered Russia’s Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said on Sunday. Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.

“Seventeen healthy volunteers were administered Sputnik V vaccine in the last three days as part of human trials,” Dr S K Raut, Head of Clinical Research Department of Noble Hospital here, said. The inoculation process began on Thursday, he added.

“All the volunteers, who were administered the vaccine, will be under observation for the next few days,” Dr Raut added. The selection of the volunteers was done as per the laid-down norms as they need to be healthy, doctors said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Vaccine Maitri Diplomacy: Special flights take off for Brazil, Morocco with COVIDSHIELD vaccine in the wee hours
2Samples of dead cranes in Delhi zoo test negative for bid flu: Officials
3Study sheds more light on role played by immune system’s T cells against coronavirus